A Snapshot of Photoresponsive Liposomes in Cancer Chemotherapy and Immunotherapy: Opportunities and Challenges.
Rana A YounessAdham H MohamedEleni K EfthimiadouRadwa Y MekkyMaria BraoudakiSherif Ashraf FahmyPublished in: ACS omega (2023)
To provide precise medical regimens, photonics technologies have been involved in the field of nanomedicine. Phototriggered liposomes have been cast as promising nanosystems that achieve controlled release of payloads in several pathological conditions such as cancer, autoimmune, and infectious diseases. In contrast to the conventional liposomes, this photoresponsive element greatly improves therapeutic efficacy and reduces the adverse effects of gene/drug therapy during treatment. Recently, cancer immunotherpay has been one of the hot topics in the field of oncology due to the great success and therapeutic benefits that were well-recognized by the patients. However, several side effects have been encountered due to the unmonitored augmentation of the immune system. This Review highlights the most recent advancements in the development of photoresponsive liposome nanosystems in the field of oncology, with a specific emphasis on challenges and opportunities in the field of cancer immunotherapy.
Keyphrases
- papillary thyroid
- drug delivery
- squamous cell
- infectious diseases
- palliative care
- end stage renal disease
- healthcare
- ejection fraction
- magnetic resonance
- chronic kidney disease
- stem cells
- emergency department
- multiple sclerosis
- lymph node metastasis
- gene expression
- magnetic resonance imaging
- prognostic factors
- dna methylation
- genome wide
- cancer therapy
- peritoneal dialysis
- locally advanced
- cell therapy
- genome wide identification
- genome wide analysis